• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

突尼斯献血者(门诊患者)、有症状患者及对照人群中幽门螺杆菌的血清阳性率。

Seroprevalence of Helicobacter pylori among Tunisian blood donors (outpatients), symptomatic patients and control subjects.

作者信息

Mansour K B, Keita A, Zribi M, Masmoudi A, Zarrouk S, Labbene M, Kallel L, Karoui S, Fekih M, Matri S, Boubaker J, Cheikh I, Chouaib S, Filali A, Mami N B, Najjar T, Fendri C

机构信息

Laboratoire de microbiologie, UR04SP08, CHU Rabta, 1007 El Jebbari, Tunis, Tunisia. khansa

出版信息

Gastroenterol Clin Biol. 2010 Jan;34(1):75-82. doi: 10.1016/j.gcb.2009.06.015. Epub 2009 Oct 29.

DOI:10.1016/j.gcb.2009.06.015
PMID:19879082
Abstract

OBJECTIVES

Helicobacter pylori is a worldwide infection, although little data are available in the Tunisian population. The aims of our study were to detect the prevalence of H. pylori in a blood-donor population (n=250) and in another population of hospital-consulting patients comprising 87 symptomatic patients and 59 controls, and to determine the factors that influence the prevalence.

MATERIALS AND METHODS

Study subjects answered a standardized questionnaire, and IgG anti-H. pylori and anti-cag were detected by ELISA. In the second population, culture and cagA polymerase chain reaction were performed.

RESULTS

The seroprevalence of H. pylori in blood donors was 64%, and 11% had anti-cag. All patients positive for anti-cag were also positive for anti-H. pylori antibodies. The seroprevalence of H. pylori was 99.3% in the hospital-consulting patients, of whom 55.5% were positive for anti-cag. The difference between the anti-cag and symptomatic patients (66.7%) and controls (39%) was significant. Symptomatic patients had a higher rate of anti-cag (66.7%) compared with the controls (39%) and blood donors (11%).

CONCLUSION

H. pylori seroprevalence in blood donors is low (64%) compared with symptomatic patients (99.3%), and anti-cag was statistically associated with symptomatic patients and pathology. Also, some environmental factors were correlated with H. pylori seroprevalence.

摘要

目的

幽门螺杆菌感染在全球范围内普遍存在,不过关于突尼斯人群的相关数据较少。我们研究的目的是检测献血者人群(n = 250)以及另一组由87名有症状患者和59名对照组成的医院门诊患者人群中幽门螺杆菌的感染率,并确定影响感染率的因素。

材料与方法

研究对象回答一份标准化问卷,采用酶联免疫吸附测定法检测抗幽门螺杆菌IgG和抗细胞毒素相关基因A(cagA)抗体。对第二组人群进行培养和cagA聚合酶链反应检测。

结果

献血者中幽门螺杆菌血清阳性率为64%,11%的人有抗cagA抗体。所有抗cagA阳性患者的抗幽门螺杆菌抗体也呈阳性。医院门诊患者中幽门螺杆菌血清阳性率为99.3%,其中55.5%的人抗cagA呈阳性。抗cagA抗体在有症状患者(66.7%)和对照(39%)之间的差异具有统计学意义。与对照(39%)和献血者(11%)相比,有症状患者的抗cagA抗体阳性率更高(66.7%)。

结论

与有症状患者(99.3%)相比,献血者中幽门螺杆菌血清阳性率较低(64%),抗cagA抗体与有症状患者及病理情况存在统计学关联。此外,一些环境因素与幽门螺杆菌血清阳性率相关。

相似文献

1
Seroprevalence of Helicobacter pylori among Tunisian blood donors (outpatients), symptomatic patients and control subjects.突尼斯献血者(门诊患者)、有症状患者及对照人群中幽门螺杆菌的血清阳性率。
Gastroenterol Clin Biol. 2010 Jan;34(1):75-82. doi: 10.1016/j.gcb.2009.06.015. Epub 2009 Oct 29.
2
Helicobacter pylori (H. pylori) infection in coronary artery disease: influence of H. pylori eradication on coronary artery lumen after percutaneous transluminal coronary angioplasty. The detection of H. pylori specific DNA in human coronary atherosclerotic plaque.幽门螺杆菌(H. pylori)感染与冠状动脉疾病:经皮冠状动脉腔内血管成形术后幽门螺杆菌根除对冠状动脉管腔的影响。人冠状动脉粥样硬化斑块中幽门螺杆菌特异性DNA的检测。
J Physiol Pharmacol. 2001 Aug;52(1 Suppl 1):3-31.
3
[Helicobacter pylori genotypes and their association with host's immune response].[幽门螺杆菌基因型及其与宿主免疫反应的关联]
Rev Gastroenterol Mex. 2002 Jul-Sep;67(3):155-60.
4
[Relation between infection of CagA-positive Helicobacter pylori and upper gastrointestinal diseases].[细胞毒素相关基因A阳性幽门螺杆菌感染与上消化道疾病的关系]
Zhonghua Yi Xue Za Zhi. 2001 Jun 10;81(11):648-50.
5
[Seroprevalence of Helicobacter pylori anti-CagA antibodies and its relationship with epidemiologic factors in Santa Fe].[圣达菲地区幽门螺杆菌抗CagA抗体血清流行率及其与流行病学因素的关系]
Acta Gastroenterol Latinoam. 2004;34(1):16-20.
6
Helicobacter pylori and gastric lymphoma: high seroprevalence of CagA in diffuse large B-cell lymphoma but not in low-grade lymphoma of mucosa-associated lymphoid tissue type.幽门螺杆菌与胃淋巴瘤:细胞毒素相关基因A(CagA)在弥漫性大B细胞淋巴瘤中血清阳性率高,而在黏膜相关淋巴组织型低度淋巴瘤中血清阳性率不高。
Am J Gastroenterol. 2001 Aug;96(8):2324-8. doi: 10.1111/j.1572-0241.2001.04036.x.
7
Helicobacter pylori seroprevalence in patients with chronic obstructive pulmonary disease.慢性阻塞性肺疾病患者的幽门螺杆菌血清阳性率
Respir Med. 2005 Mar;99(3):279-84. doi: 10.1016/j.rmed.2004.08.007.
8
Helicobacter pylori seroprevalence in symptomatic veterans: a study of 7310 patients over 11 years.有症状退伍军人中幽门螺杆菌血清流行率:一项对7310名患者长达11年的研究。
Helicobacter. 2009 Aug;14(4):298-302. doi: 10.1111/j.1523-5378.2009.00693.x.
9
Seroreactivity to specific antigens of Helicobacter pylori infection is associated with an increased risk of the dyspeptic gastrointestinal diseases.对幽门螺杆菌感染特定抗原的血清反应性与消化不良性胃肠疾病风险增加相关。
Int J Infect Dis. 2009 Sep;13(5):647-54. doi: 10.1016/j.ijid.2008.12.013. Epub 2009 Feb 23.
10
Serum antibodies to enterohepatic Helicobacter spp. in patients with chronic liver diseases and in a population with high prevalence of H. pylori infection.慢性肝病患者及幽门螺杆菌感染高流行率人群中针对肝肠螺杆菌属的血清抗体。
Dig Liver Dis. 2006 Mar;38(3):171-6. doi: 10.1016/j.dld.2005.12.008. Epub 2006 Feb 7.

引用本文的文献

1
Assessment of cytotoxin-associated Gene A (Cag A) protein and its association with ferritin and vitamin B12 deficiencies among adult healthy asymptomatic residents in Sharjah, United Arab Emirates.阿拉伯联合酋长国沙迦成年健康无症状居民中细胞毒素相关基因A(Cag A)蛋白的评估及其与铁蛋白和维生素B12缺乏的关联。
Heliyon. 2024 May 29;10(11):e32141. doi: 10.1016/j.heliyon.2024.e32141. eCollection 2024 Jun 15.
2
Eradication of : a prospective comparative randomized trial of standard versus optimized quadruple therapy.根除治疗:标准四联疗法与优化四联疗法的前瞻性比较随机试验
Future Sci OA. 2024 May 15;10(1):FSO974. doi: 10.2144/fsoa-2023-0316. eCollection 2024.
3
infection in humans and phytotherapy, probiotics, and emerging therapeutic interventions: a review.
人类感染与植物疗法、益生菌及新兴治疗干预措施:综述
Front Microbiol. 2024 Jan 10;14:1330029. doi: 10.3389/fmicb.2023.1330029. eCollection 2023.
4
Treatment of infection 14-day concomitant quadruple therapy versus triple therapy: A parallel double-blind randomized controlled trial.治疗感染:14天联合四联疗法与三联疗法对比:一项平行双盲随机对照试验。
Health Sci Rep. 2023 Oct 4;6(10):e1593. doi: 10.1002/hsr2.1593. eCollection 2023 Oct.
5
Prevalence of and Its Associated Factors among Healthy Asymptomatic Residents in the United Arab Emirates.阿拉伯联合酋长国健康无症状居民中的患病率及其相关因素。
Pathogens. 2019 Apr 1;8(2):44. doi: 10.3390/pathogens8020044.
6
A review of the infection-associated cancers in North African countries.北非国家感染相关癌症综述。
Infect Agent Cancer. 2016 Aug 10;11:35. doi: 10.1186/s13027-016-0083-8. eCollection 2016.
7
Epidemiology of Helicobacter pylori infection among the healthy population in Iran and countries of the Eastern Mediterranean Region: a systematic review of prevalence and risk factors.伊朗及东地中海区域各国健康人群幽门螺杆菌感染的流行病学:患病率及危险因素的系统评价
World J Gastroenterol. 2014 Dec 14;20(46):17618-25. doi: 10.3748/wjg.v20.i46.17618.
8
Anemia and Helicobacter pylori seroreactivity in a rural Haitian population.海地农村人群贫血与幽门螺杆菌血清反应性。
Am J Trop Med Hyg. 2011 Nov;85(5):913-8. doi: 10.4269/ajtmh.2011.11-0101.